Feeding butter with elevated content of trans-10, cis-12 conjugated linoleic acid to obese-prone rats impairs glucose and insulin tolerance

Lipids Health Dis. 2015 Sep 28:14:119. doi: 10.1186/s12944-015-0122-2.

Abstract

Background: We recently demonstrated that feeding a natural CLAt10,c12-enriched butter to lean female rats resulted in small, but significant increases in fasting glucose and insulin concentrations, and impaired insulin tolerance. Our goal was to extend these findings by utilizing the diabetes-prone female fatty Zucker rat. Rats were fed custom diets containing 45 % kcal of fat derived from control and CLAt10,c12-enriched butter for 8 weeks.

Methods: CLA t10,c12-enriched butter was prepared from milk collected from cows fed a high fermentable carbohydrate diet to create subacute rumen acidosis (SARA); control (non-SARA) butter was collected from cows fed a low grain diet. Female fatty Zucker rats (10 weeks old) were randomly assigned to one of four diet treatments: i) low fat (10 % kcal), ii) 45 % kcal lard, iii) 45 % kcal SARA butter, or iv) 45 % kcal non-SARA butter. A low fat fed lean Zucker group was used as a control group. After 8 weeks, i) glucose and insulin tolerance tests, ii) insulin signaling in muscle, adipose and liver, and iii) metabolic caging measurements were performed.

Results: Glucose and insulin tolerance were significantly impaired in all fatty Zucker groups, but to the greatest extent in the LARD and SARA conditions. Insulin signaling (AKT phosphorylation) was impaired in muscle, visceral (perigonadal) adipose tissue and liver in fatty Zucker rats, but was generally similar across dietary groups. Physical activity, oxygen consumption, food intake and weight gain were also similar amongst the various fatty Zucker groups.

Conclusions: Increasing the consumption of a food naturally enriched with CLAt10,c12 significantly worsens glucose and insulin tolerance in a diabetes-prone rodent model. This outcome is not explained by changes in tissue insulin signaling, physical activity, energy expenditure, food intake or body mass.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / metabolism*
  • Butter / adverse effects
  • Diet, High-Fat / adverse effects*
  • Eating / physiology
  • Female
  • Glucose Tolerance Test
  • Insulin / metabolism
  • Insulin Resistance*
  • Intra-Abdominal Fat / drug effects
  • Intra-Abdominal Fat / metabolism
  • Linoleic Acids, Conjugated / administration & dosage
  • Linoleic Acids, Conjugated / adverse effects*
  • Liver / drug effects
  • Liver / metabolism
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism
  • Obesity / etiology
  • Obesity / metabolism*
  • Oxygen Consumption / physiology
  • Rats
  • Rats, Zucker
  • Weight Gain / physiology

Substances

  • Blood Glucose
  • Insulin
  • Linoleic Acids, Conjugated
  • Butter